Post Traumatic Stress Disorder Medications

Definition of Post Traumatic Stress Disorder: Development of characteristic symptoms following a psychologically traumatic event that is generally outside the range of usual human experience; symptoms include numbed responsiveness to environmental stimuli, a variety of autonomic and cognitive dysfunctions, and dysphoria. More...

Drugs associated with Post Traumatic Stress Disorder

The following drugs and medications are in some way related to, or used in the treatment of Post Traumatic Stress Disorder. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Post Traumatic Stress Disorder

Medical Encyclopedia:

• Post-traumatic stress disorder

Drug List:

Abilify

Abilify-Discmelt-Orally-Disintegrating-Tablets

Elavil

Paxil

Pristiq

Saphris

Seroquel

Seroquel-Xr-Sustained-Release-Tablets

Vanatrip

Zoloft

Dioxaflex Gel

Dioxaflex Gel may be available in the countries listed below.

Ingredient matches for Dioxaflex Gel

Diclofenac

Diclofenac is reported as an ingredient of Dioxaflex Gel in the following countries:

• Peru

International Drug Name Search

Polymyositis/Dermatomyositis Medications

Definition of Polymyositis/Dermatomyositis: A connective tissue disease, which is characterized by inflammation and degeneration of the muscles.

Drugs associated with Polymyositis/Dermatomyositis

The following drugs and medications are in some way related to, or used in the treatment of Polymyositis/Dermatomyositis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Polymyositis/Dermatomyositis

Micromedex Care Notes:

• Dermatomyositis
• Polymyositis

Medical Encyclopedia:

• Dermatomyositis
• Polymyositis - adult

Drug List:

Carimune-Igiv

Deltasone

Flebogamma

Gamimune

Gamimune-N-10-Igiv

Gammagard

Gammagard-S-D-Igiv

Gammaplex-Igiv

Gammar-Piv

Iveegam-En-Igiv

Meticorten

Octagam

Panglobulin-Nf

Polygam-S-D-Igiv

Privigen

Sandoglobulin-Igiv

Sterapred

Sterapred-Ds

Virmen Topico

Virmen Topico may be available in the countries listed below.

Ingredient matches for Virmen Topico

Acyclovir

Aciclovir is reported as an ingredient of Virmen Topico in the following countries:

• Spain

International Drug Name Search

Noneston

Noneston may be available in the countries listed below.

Ingredient matches for Noneston

Sulpiride

Sulpiride is reported as an ingredient of Noneston in the following countries:

• Greece

International Drug Name Search

Dantron 8

Dantron 8 may be available in the countries listed below.

Ingredient matches for Dantron 8

Ondansetron

Ondansetron hydrochloride dihydrate (a derivative of Ondansetron) is reported as an ingredient of Dantron 8 in the following countries:

• South Africa

International Drug Name Search

Damizol

Damizol may be available in the countries listed below.

Ingredient matches for Damizol

Midazolam

Midazolam is reported as an ingredient of Damizol in the following countries:

• Greece

International Drug Name Search

Nicométhanol

Nicométhanol may be available in the countries listed below.

Ingredient matches for Nicométhanol

Nicotinyl Alcohol

Nicométhanol (DCF) is also known as Nicotinyl Alcohol (USAN)

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Naproxene sodico Dorom

Naproxene sodico Dorom may be available in the countries listed below.

Ingredient matches for Naproxene sodico Dorom

Naproxen

Naproxen sodium salt (a derivative of Naproxen) is reported as an ingredient of Naproxene sodico Dorom in the following countries:

• Italy

International Drug Name Search

Oftalmolosa Cusi Prednisona Neomicina

Oftalmolosa Cusi Prednisona Neomicina may be available in the countries listed below.

Ingredient matches for Oftalmolosa Cusi Prednisona Neomicina

Neomycin

Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Oftalmolosa Cusi Prednisona Neomicina in the following countries:

• Spain

Prednisone

Prednisone is reported as an ingredient of Oftalmolosa Cusi Prednisona Neomicina in the following countries:

• Spain

International Drug Name Search

Selectol

Selectol may be available in the countries listed below.

Ingredient matches for Selectol

Celiprolol

Celiprolol hydrochloride (a derivative of Celiprolol) is reported as an ingredient of Selectol in the following countries:

• Austria


• Belgium


• Chile


• Finland


• Germany


• Greece


• Hong Kong


• Ireland


• Japan


• Luxembourg


• Switzerland

International Drug Name Search

Sonke-LamiNevStav

Sonke-LamiNevStav may be available in the countries listed below.

Ingredient matches for Sonke-LamiNevStav

Lamivudine

Lamivudine is reported as an ingredient of Sonke-LamiNevStav in the following countries:

• South Africa

Nevirapine

Nevirapine is reported as an ingredient of Sonke-LamiNevStav in the following countries:

• South Africa

Stavudine

Stavudine is reported as an ingredient of Sonke-LamiNevStav in the following countries:

• South Africa

International Drug Name Search

Odanon

Odanon may be available in the countries listed below.

Ingredient matches for Odanon

Carbazochrome

Carbazochrome sodium sulfonate (a derivative of Carbazochrome) is reported as an ingredient of Odanon in the following countries:

• Japan

International Drug Name Search

Zyrona

Zyrona may be available in the countries listed below.

Ingredient matches for Zyrona

Cyproterone

Cyproterone 17α-acetate (a derivative of Cyproterone) is reported as an ingredient of Zyrona in the following countries:

• Denmark


• Sweden

Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Zyrona in the following countries:

• Denmark


• Sweden

International Drug Name Search

Opicillin

Opicillin may be available in the countries listed below.

Ingredient matches for Opicillin

Ampicillin

Ampicillin trihydrate (a derivative of Ampicillin) is reported as an ingredient of Opicillin in the following countries:

• Indonesia

International Drug Name Search

Doxilamina

Doxilamina may be available in the countries listed below.

Ingredient matches for Doxilamina

Doxylamine

Doxilamina (DCIT) is known as Doxylamine in the US.

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Sulfate de Magnesium

Sulfate de Magnesium may be available in the countries listed below.

Ingredient matches for Sulfate de Magnesium

Magnesium Sulfate

Magnesium Sulfate is reported as an ingredient of Sulfate de Magnesium in the following countries:

• Tunisia

International Drug Name Search

Scholl Medicinski flaster

Scholl Medicinski flaster may be available in the countries listed below.

Ingredient matches for Scholl Medicinski flaster

Salicylic Acid

Salicylic Acid is reported as an ingredient of Scholl Medicinski flaster in the following countries:

• Croatia (Hrvatska)

International Drug Name Search

Sibital

Sibital may be available in the countries listed below.

Ingredient matches for Sibital

Phenobarbital

Phenobarbital sodium salt (a derivative of Phenobarbital) is reported as an ingredient of Sibital in the following countries:

• Indonesia

International Drug Name Search

Dobucor

Dobucor may be available in the countries listed below.

Ingredient matches for Dobucor

Dobutamine

Dobutamine hydrochloride (a derivative of Dobutamine) is reported as an ingredient of Dobucor in the following countries:

• Spain

International Drug Name Search

Unipres

In the US, Unipres is a member of the drug class antihypertensive combinations and is used to treat High Blood Pressure.

Ingredient matches for Unipres

Nitrendipine

Nitrendipine is reported as an ingredient of Unipres in the following countries:

• Czech Republic


• Hungary


• Lithuania


• Romania


• Slovenia

International Drug Name Search

Hamiltosin

Hamiltosin may be available in the countries listed below.

Ingredient matches for Hamiltosin

Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Hamiltosin in the following countries:

• Greece

International Drug Name Search

Volmagen

Volmagen may be available in the countries listed below.

Ingredient matches for Volmagen

Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Volmagen in the following countries:

• Japan

International Drug Name Search

Omeprazol Kern

Omeprazol Kern may be available in the countries listed below.

Ingredient matches for Omeprazol Kern

Omeprazole

Omeprazole is reported as an ingredient of Omeprazol Kern in the following countries:

• Spain

International Drug Name Search

Symmetrel

In some countries, this medicine may only be approved for veterinary use.

In the US, Symmetrel (amantadine systemic) is a member of the following drug classes: adamantane antivirals, dopaminergic antiparkinsonism agents and is used to treat Chronic Fatigue Syndrome, Extrapyramidal Reaction, Influenza, Influenza Prophylaxis, Multiple Sclerosis, Parkinson's Disease, Post-Polio Syndrome and Sexual Dysfunction - SSRI Induced.

US matches:

• Symmetrel

UK matches:

• Symmetrel Capsules (SPC)
• Symmetrel Syrup (SPC)

Ingredient matches for Symmetrel

Amantadine

Amantadine hydrochloride (a derivative of Amantadine) is reported as an ingredient of Symmetrel in the following countries:

• Australia


• Greece


• Japan


• Netherlands


• New Zealand


• Oman


• Singapore


• South Africa


• Switzerland


• United Kingdom


• United States


• Venezuela

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

DexaEDO

DexaEDO may be available in the countries listed below.

Ingredient matches for DexaEDO

Dexamethasone

Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of DexaEDO in the following countries:

• Germany


• Serbia

International Drug Name Search

Oxybutynin Chloride Tablets

Ingredient matches for Oxybutynin Chloride Tablets

Oxybutynin

Oxybutynin hydrochloride (a derivative of Oxybutynin) is reported as an ingredient of Oxybutynin Chloride Tablets in the following countries:

• United States

International Drug Name Search

Sertraline Ranbaxy

Sertraline Ranbaxy may be available in the countries listed below.

Ingredient matches for Sertraline Ranbaxy

Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertraline Ranbaxy in the following countries:

• France


• Netherlands

International Drug Name Search

Declomycin

In the US, Declomycin (demeclocycline systemic) is a member of the drug class tetracyclines and is used to treat SIADH.

US matches:

• Declomycin

Ingredient matches for Declomycin

Demeclocycline

Demeclocycline hydrochloride (a derivative of Demeclocycline) is reported as an ingredient of Declomycin in the following countries:

• United States

International Drug Name Search

Selbex

Selbex may be available in the countries listed below.

Ingredient matches for Selbex

Teprenone

Teprenone is reported as an ingredient of Selbex in the following countries:

• China


• Dominican Republic


• El Salvador


• Japan


• Myanmar


• Philippines


• Thailand


• Vietnam

International Drug Name Search

Tinea Pedis Medications

Definition of Tinea Pedis: Tinea pedis is an infection of the feet with mold-like fungi called dermatophytes. More...

Drugs associated with Tinea Pedis

The following drugs and medications are in some way related to, or used in the treatment of Tinea Pedis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Tinea Pedis

Medical Encyclopedia:

• Athlete's foot

Drug List:

Absorbine-Athletes-Foot

Absorbine-Jr-Cream

Absorbine-Jr-Antifungal

Aftate-Spray

Aftate-For-Athletes-Foot

Aloe-Vesta

Aloe-Vesta-2-In-1-Antifungal

Athletes-Foot-Cream

Baza

Blis-To-Sol

Blis-To-Sol-Powder

Canesten-Topical

Cnl8-Solution-Kit

Cruex

Cruex-Prescription-Strength

Derma-Gran-Af-Topical

Desenex-Spray

Desenex-Af-Prescription-Strength

Desenex-Prescription-Strength

Desenex-Spray

Dr-Scholl-S-Fungal-Nail-Management-Kit-Cream-Kit

Elon-Dual-Defense-Anti-Fungal-Liquid

Ertaczo

Exelderm-Cream

Extina

Fulvicin-P-G

Fulvicin-U-F

Fungatin

Fungi-Guard

Fungicure-Pump-Spray

Fungoid

Fungoid-Kit

Genaspor

Gordochom

Grifulvin-V-Microsize

Gris-Peg-Ultramicrosize-Tablets

Grisactin-250

Grisactin-500

Grisactin-Ultra

Hongos

Iodo-Plain

Kuric-Cream

Lamisil

Lamisil-At-Cream

Loprox-Cream

Loprox-Ts-Topical

Lotrimin-Af-Lotion

Lotrimin-Af-Powder

Lotrimin-Af-For-Her

Lotrisone

Mentax-Cream

Micatin-Cream

Micatin-Cooling-Action

Micatin-Foot-Powder

Micatin-Foot-Powder-Deodorant

Micatin-Liquid-Foot

Micro-Guard-Topical

Miranel-Af-Liquid

Mitrazol

Monistat-Derm-Cream

Mycelex-Cream

Mycelex-Otc

Naftin-Cream

Naftin-Mp-Cream

Nizoral-A-D-Shampoo

Nizoral-Cream

Np-27

Ony-Clear

Oxistat-Cream

Podactin

Protectol

Q-Naftate-Topical

Secura-Antifungal-Topical

Spectazole-Cream

T-Athlete

Tetterine-Cream

Tinactin-Cream

Tinactin-Jock-Itch-Topical

Tinaderm-Topical

Tinamar-Powder

Tinaspore

Ting

Trifungol-Liquid

Undelenic

Xolegel

Zeasorb-Af-Gel

Corneal Ulcer Medications

Definition of Corneal Ulcer:

An infectious process of the cornea, resulting in clouding of the cornea, marked eye pain and decreased vision.

See: Herpes simplex keratitis.

More...

Drugs associated with Corneal Ulcer

The following drugs and medications are in some way related to, or used in the treatment of Corneal Ulcer. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Corneal Ulcer

Medical Encyclopedia:

• Corneal ulcers and infections

Drug List:

Ciloxan-Drops

Deltasone

Meticorten

Ocuflox-Drops

Sterapred

Sterapred-Ds

Voltaren-Drops

Stamicin

Stamicin may be available in the countries listed below.

Ingredient matches for Stamicin

Nystatin

Nystatin is reported as an ingredient of Stamicin in the following countries:

• Romania

International Drug Name Search

Ulcefate

Ulcefate may be available in the countries listed below.

Ingredient matches for Ulcefate

Sucralfate

Sucralfate is reported as an ingredient of Ulcefate in the following countries:

• Thailand

International Drug Name Search

Virbamec Oral

Virbamec Oral may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Virbamec Oral

Abamectin

Abamectin is reported as an ingredient of Virbamec Oral in the following countries:

• Australia

International Drug Name Search

Daxotel

Daxotel may be available in the countries listed below.

Ingredient matches for Daxotel

Docetaxel

Docetaxel is reported as an ingredient of Daxotel in the following countries:

• Georgia


• Venezuela

Docetaxel trihydrate (a derivative of Docetaxel) is reported as an ingredient of Daxotel in the following countries:

• India


• Philippines

Doxorubicin

Doxorubicin hydrochloride (a derivative of Doxorubicin) is reported as an ingredient of Daxotel in the following countries:

• Chile

International Drug Name Search

Sumatriptan-CT

Sumatriptan-CT may be available in the countries listed below.

Ingredient matches for Sumatriptan-CT

Sumatriptan

Sumatriptan succinate (a derivative of Sumatriptan) is reported as an ingredient of Sumatriptan-CT in the following countries:

• Germany

International Drug Name Search

Heparin Sodium Panpharma

Heparin Sodium Panpharma may be available in the countries listed below.

Ingredient matches for Heparin Sodium Panpharma

Heparin

Heparin sodium salt (a derivative of Heparin) is reported as an ingredient of Heparin Sodium Panpharma in the following countries:

• Lithuania

International Drug Name Search

Niquitinminis

Niquitinminis may be available in the countries listed below.

Ingredient matches for Niquitinminis

Nicotine

Nicotine resinate (a derivative of Nicotine) is reported as an ingredient of Niquitinminis in the following countries:

• France

International Drug Name Search

Nifuroxazide EG

Nifuroxazide EG may be available in the countries listed below.

Ingredient matches for Nifuroxazide EG

Nifuroxazide

Nifuroxazide is reported as an ingredient of Nifuroxazide EG in the following countries:

• France

International Drug Name Search

Cleocin T

See also: Generic Cleocin Vaginal

Cleocin T is a brand name of clindamycin topical, approved by the FDA in the following formulation(s):

CLEOCIN T (clindamycin phosphate - gel; topical)

• 
  Manufacturer: PHARMACIA AND UPJOHN
  
  Approval date: January 7, 1987
  
  Strength(s): EQ 1% BASE ^[RLD][AB]

CLEOCIN T (clindamycin phosphate - lotion; topical)

• 
  Manufacturer: PHARMACIA AND UPJOHN
  
  Approval date: May 31, 1989
  
  Strength(s): EQ 1% BASE ^[RLD][AB]

CLEOCIN T (clindamycin phosphate - solution; topical)

• 
  Manufacturer: PHARMACIA AND UPJOHN
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): EQ 1% BASE ^[RLD][AT]

Has a generic version of Cleocin T been approved?

Yes. The following products are equivalent to Cleocin T:

CLINDA-DERM (clindamycin phosphate solution; topical)

• 
  Manufacturer: PADDOCK LLC
  
  Approval date: September 30, 1992
  
  Strength(s): EQ 1% BASE ^[AT]

clindamycin phosphate gel; topical

• 
  Manufacturer: FOUGERA PHARMS
  
  Approval date: January 28, 2000
  
  Strength(s): EQ 1% BASE ^[AB]

clindamycin phosphate lotion; topical

• 
  Manufacturer: FOUGERA PHARMS
  
  Approval date: January 31, 2002
  
  Strength(s): EQ 1% BASE ^[AB]

clindamycin phosphate solution; topical

• 
  Manufacturer: FOUGERA
  
  Approval date: June 5, 1997
  
  Strength(s): EQ 1% BASE ^[AT]


• 
  Manufacturer: FOUGERA PHARMS
  
  Approval date: February 14, 2006
  
  Strength(s): EQ 1% BASE ^[AT]


• 
  Manufacturer: PERRIGO NEW YORK
  
  Approval date: November 30, 1995
  
  Strength(s): EQ 1% BASE ^[AT]


• 
  Manufacturer: TARO PHARM INDS
  
  Approval date: March 31, 2004
  
  Strength(s): EQ 1% BASE ^[AT]


• 
  Manufacturer: WOCKHARDT
  
  Approval date: July 15, 1997
  
  Strength(s): EQ 1% BASE ^[AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cleocin T. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Cleocin T.

See also...

• Cleocin T Gel Consumer Information (Wolters Kluwer)
• Cleocin T Lotion Consumer Information (Wolters Kluwer)
• Cleocin T Solution Consumer Information (Wolters Kluwer)
• Cleocin T Swab Consumer Information (Wolters Kluwer)
• Cleocin T Consumer Information (Cerner Multum)
• Cleocin T Topical Advanced Consumer Information (Micromedex)
• Clindamycin Cream Consumer Information (Wolters Kluwer)
• Clindamycin Foam Consumer Information (Wolters Kluwer)
• Clindamycin Gel Consumer Information (Wolters Kluwer)
• Clindamycin Lotion Consumer Information (Wolters Kluwer)
• Clindamycin Solution Consumer Information (Wolters Kluwer)
• Clindamycin Suppositories Consumer Information (Wolters Kluwer)
• Clindamycin Swab Consumer Information (Wolters Kluwer)
• Clindamycin topical Consumer Information (Cerner Multum)
• Clindamycin vaginal Consumer Information (Cerner Multum)
• Z-Clinz Topical Advanced Consumer Information (Micromedex)
• Clindamycin Topical Advanced Consumer Information (Micromedex)
• Clindamycin Vaginal Advanced Consumer Information (Micromedex)
• Clindamycin Phosphate topical AHFS DI Monographs (ASHP)

Orbeseal

Orbeseal may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Orbeseal

Bismuth Subnitrate

Bismuth Subnitrate is reported as an ingredient of Orbeseal in the following countries:

• Austria


• Belgium


• Finland


• France


• Germany


• Italy


• Netherlands


• Norway


• Switzerland

International Drug Name Search

Numorphan

In some countries, this medicine may only be approved for veterinary use.

In the US, Numorphan (oxymorphone systemic) is a member of the drug class narcotic analgesics and is used to treat Labor Pain and Pain.

US matches:

• Numorphan


• Numorphan Suppositories

Ingredient matches for Numorphan

Oxymorphone

Oxymorphone hydrochloride (a derivative of Oxymorphone) is reported as an ingredient of Numorphan in the following countries:

• United States

International Drug Name Search

Zolpimist

Zolpimist is a brand name of zolpidem, approved by the FDA in the following formulation(s):

ZOLPIMIST (zolpidem tartrate - spray, metered; oral)

• 
  Manufacturer: NOVADEL
  
  Approval date: December 19, 2008
  
  Strength(s): 5MG/SPRAY ^[RLD]

Has a generic version of Zolpimist been approved?

No. There is currently no therapeutically equivalent version of Zolpimist available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zolpimist. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Buccal, polar and non-polar spray containing zolpidem
  Patent 7,632,517
  Issued: December 15, 2009
  Inventor(s): Dugger, III; Harry A. & Abd El-Shafy; Mohammed
  Assignee(s): Novadel Pharma Inc.
  Buccal aerosol sprays or capsules using polar and non-polar solvents have now been developed which provide zolpidem for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal polar compositions of the invention comprise formulation I: aqueous polar solvent, zolpidem, and optional flavoring agent; formulation II: aqueous polar solvent, zolpidem, optionally flavoring agent, and propellant; formulation III: non-polar solvent, zolpidem, and optional flavoring agent; formulation IV: non-polar solvent, zolpidem, optional flavoring agent, and propellant; formulation V: a mixture of a polar solvent and a non-polar solvent, zolpidem, and optional flavoring agent; formulation VI: a mixture of a polar solvent and a non-polar solvent, zolpidem, optional flavoring agent, and propellant.
  
  Patent expiration dates:
  
  
  • October 1, 2017
    
    ✓ 
    Patent use: TREATMENT OF TRANSIENT INSOMNIA
  
  

See also...

• ZolpiMist Consumer Information (Drugs.com)
• Zolpimist Oral Spray Consumer Information (Wolters Kluwer)
• Zolpimist Consumer Information (Cerner Multum)
• Zolpimist Advanced Consumer Information (Micromedex)
• Zolpidem Consumer Information (Drugs.com)
• Zolpidem Consumer Information (Wolters Kluwer)
• Zolpidem Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Zolpidem Oral Spray Consumer Information (Wolters Kluwer)
• Zolpidem Consumer Information (Cerner Multum)
• Zolpidem Oral, Oromucosal Advanced Consumer Information (Micromedex)
• Zolpidem Tartrate AHFS DI Monographs (ASHP)

Neurelark

Neurelark may be available in the countries listed below.

Ingredient matches for Neurelark

Tiapride

Tiapride hydrochloride (a derivative of Tiapride) is reported as an ingredient of Neurelark in the following countries:

• Japan

International Drug Name Search

Neo-Sintrom

Neo-Sintrom may be available in the countries listed below.

Ingredient matches for Neo-Sintrom

Acenocoumarol

Acenocoumarol is reported as an ingredient of Neo-Sintrom in the following countries:

• Chile

International Drug Name Search

Sophtal

Sophtal may be available in the countries listed below.

Ingredient matches for Sophtal

Salicylic Acid

Salicylic Acid is reported as an ingredient of Sophtal in the following countries:

• France

International Drug Name Search

Vitamina C Genfar

Vitamina C Genfar may be available in the countries listed below.

Ingredient matches for Vitamina C Genfar

Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Vitamina C Genfar in the following countries:

• Chile


• Colombia


• Ecuador

International Drug Name Search

Zensoderm

Zensoderm may be available in the countries listed below.

Ingredient matches for Zensoderm

Betamethasone

Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Zensoderm in the following countries:

• Indonesia

Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Zensoderm in the following countries:

• Indonesia

International Drug Name Search

Mycobutin

Mycobutin is a brand name of rifabutin, approved by the FDA in the following formulation(s):

MYCOBUTIN (rifabutin - capsule; oral)

• 
  Manufacturer: PHARMACIA AND UPJOHN
  
  Approval date: December 23, 1992
  
  Strength(s): 150MG ^[RLD]

Has a generic version of Mycobutin been approved?

No. There is currently no therapeutically equivalent version of Mycobutin available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Mycobutin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Mycobutin.

See also...

• Mycobutin Consumer Information (Wolters Kluwer)
• Mycobutin Consumer Information (Cerner Multum)
• Mycobutin Advanced Consumer Information (Micromedex)
• Mycobutin AHFS DI Monographs (ASHP)
• Rifabutin Consumer Information (Wolters Kluwer)
• Rifabutin Consumer Information (Cerner Multum)
• Rifabutin Advanced Consumer Information (Micromedex)
• Rifabutin AHFS DI Monographs (ASHP)

Salticin

Salticin may be available in the countries listed below.

Ingredient matches for Salticin

Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Salticin in the following countries:

• Indonesia

International Drug Name Search

Q-Spin

Q-Spin may be available in the countries listed below.

Ingredient matches for Q-Spin

Amlodipine

Amlodipine is reported as an ingredient of Q-Spin in the following countries:

• India

International Drug Name Search

Soma

Soma is a brand name of carisoprodol, approved by the FDA in the following formulation(s):

SOMA (carisoprodol - tablet; oral)

• 
  Manufacturer: MEDA PHARMS
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 350MG ^[AA]


• 
  Manufacturer: MEDA PHARMS
  
  Approval date: September 13, 2007
  
  Strength(s): 250MG ^[RLD]

Has a generic version of Soma been approved?

A generic version of Soma has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Soma and have been approved by the FDA:

carisoprodol tablet; oral

• 
  Manufacturer: ADVENT PHARMS
  
  Approval date: June 7, 2005
  
  Strength(s): 350MG ^[AA]


• 
  Manufacturer: AUROBINDO PHARMA
  
  Approval date: August 6, 2009
  
  Strength(s): 350MG ^[AA]


• 
  Manufacturer: COREPHARMA
  
  Approval date: September 21, 2000
  
  Strength(s): 350MG ^[AA]


• 
  Manufacturer: MIRROR PHARMS
  
  Approval date: October 22, 2008
  
  Strength(s): 350MG ^[AA]


• 
  Manufacturer: MUTUAL PHARM
  
  Approval date: October 17, 1991
  
  Strength(s): 350MG ^[AA]


• 
  Manufacturer: PROSAM LABS
  
  Approval date: March 7, 1997
  
  Strength(s): 350MG ^[AA]


• 
  Manufacturer: SUN PHARM INDS LTD
  
  Approval date: February 27, 2007
  
  Strength(s): 350MG ^[AA]


• 
  Manufacturer: VINTAGE PHARMS
  
  Approval date: September 8, 1997
  
  Strength(s): 350MG ^[AA]


• 
  Manufacturer: WATSON LABS
  
  Approval date: April 20, 1982
  
  Strength(s): 350MG ^[AA]


• 
  Manufacturer: WEST WARD
  
  Approval date: January 24, 1996
  
  Strength(s): 350MG ^[AA]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Soma. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Soma.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • September 13, 2010 - NEW PRODUCT
  
  

See also...

• Soma Consumer Information (Drugs.com)
• Soma Consumer Information (Wolters Kluwer)
• Soma Consumer Information (Cerner Multum)
• Soma Advanced Consumer Information (Micromedex)
• Carisoprodol Consumer Information (Drugs.com)
• Carisoprodol Consumer Information (Wolters Kluwer)
• Carisoprodol Consumer Information (Cerner Multum)
• Carisoprodol Advanced Consumer Information (Micromedex)
• Carisoprodol AHFS DI Monographs (ASHP)

Dolirhume Paracétamol et Pseudoéphédrine

Dolirhume Paracétamol et Pseudoéphédrine may be available in the countries listed below.

Ingredient matches for Dolirhume Paracétamol et Pseudoéphédrine

Paracetamol

Paracetamol is reported as an ingredient of Dolirhume Paracétamol et Pseudoéphédrine in the following countries:

• France

Pseudoephedrine

Pseudoephedrine hydrochloride (a derivative of Pseudoephedrine) is reported as an ingredient of Dolirhume Paracétamol et Pseudoéphédrine in the following countries:

• France

International Drug Name Search

Natrijum Kromoglikat

Natrijum Kromoglikat may be available in the countries listed below.

Ingredient matches for Natrijum Kromoglikat

Cromoglicic Acid

Cromoglicic Acid disodium salt (a derivative of Cromoglicic Acid) is reported as an ingredient of Natrijum Kromoglikat in the following countries:

• Serbia

International Drug Name Search

Cuvposa

Cuvposa is a brand name of glycopyrrolate, approved by the FDA in the following formulation(s):

CUVPOSA (glycopyrrolate - solution; oral)

• 
  Manufacturer: SHIONOGI INC
  
  Approval date: July 28, 2010
  
  Strength(s): 1MG/5ML ^[RLD]

Has a generic version of Cuvposa been approved?

No. There is currently no therapeutically equivalent version of Cuvposa available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cuvposa. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Method for increasing the bioavailability of glycopyrrolate
  Patent 7,638,552
  Issued: December 29, 2009
  Inventor(s): Roberts; Alan & Venkataraman; Balaji
  Assignee(s): Sciele Pharma, Inc.
  The invention relates to a method of increasing the bioavailability of glycopyrrolate by administration of a therapeutically effective amount of glycopyrrolate without food. The invention also provides a kit comprising a pharmaceutical composition comprising a therapeutically effective amount of glycopyrrolate and a pharmaceutically acceptable carrier, prescribing information including advice regarding the administration of glycopyrrolate without food to improve bioavailability, and a container.
  
  Patent expiration dates:
  
  
  • August 20, 2023
    
    ✓ 
    Patent use: REDUCE CHRONIC SEVERE DROOLING (I.E., SIALORRHEA) IN PATIENTS WITH NEUROLOGIC CONDITIONS ASSOCIATED WITH PROBLEM DROOLING
  
  



• 
  Method for increasing the bioavailability of glycopyrrolate
  Patent 7,816,396
  Issued: October 19, 2010
  Inventor(s): Roberts; Alan & Venkataraman; Balaji
  Assignee(s): Shionogi Pharma, Inc.
  The invention relates to a method of treating sialorrhea in a human patient, which comprises orally administering glycopyrrolate in a liquid solution to the human patient under fasted conditions.
  
  Patent expiration dates:
  
  
  • August 20, 2023
    
    ✓ 
    Patent use: REDUCE CHRONIC SEVERE DROOLING (I.E., SIALORRHEA) IN PATIENTS WITH NEUROLOGIC CONDITIONS ASSOCIATED WITH PROBLEM DROOLING
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • July 28, 2013 - NEW PRODUCT
  
  

See also...

• Cuvposa Consumer Information (Drugs.com)
• Cuvposa Solution Consumer Information (Wolters Kluwer)
• Cuvposa Consumer Information (Cerner Multum)
• Cuvposa Advanced Consumer Information (Micromedex)
• Glycopyrrolate Consumer Information (Wolters Kluwer)
• Glycopyrrolate Solution Consumer Information (Wolters Kluwer)
• Glycopyrrolate Tablets Consumer Information (Wolters Kluwer)
• Glycopyrrolate Consumer Information (Cerner Multum)
• Glycopyrrolate Advanced Consumer Information (Micromedex)
• Glycopyrrolate AHFS DI Monographs (ASHP)

Simcard

Simcard may be available in the countries listed below.

Ingredient matches for Simcard

Simvastatin

Simvastatin is reported as an ingredient of Simcard in the following countries:

• Croatia (Hrvatska)


• Latvia


• South Africa


• Sri Lanka

International Drug Name Search

Bepreve

Bepreve is a brand name of bepotastine ophthalmic, approved by the FDA in the following formulation(s):

BEPREVE (bepotastine besilate - solution/drops; ophthalmic)

• 
  Manufacturer: ISTA PHARMS
  
  Approval date: September 8, 2009
  
  Strength(s): 1.5% ^[RLD]

Has a generic version of Bepreve been approved?

No. There is currently no therapeutically equivalent version of Bepreve available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Bepreve. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Acid addition salt of optically active piperidine compound and process for preparing the same
  Patent 6,780,877
  Issued: August 24, 2004
  Inventor(s): Jun-ichiro; Kita & Hiroshi; Fujiwara & Shinji; Takamura
  Assignee(s): Ube Industries, Ltd.
  Tanabe Seiyaku Co., Ltd.
  The present invention is to provide a benzenesulfonic acid salt and a benzoic acid salt of (S)-4-[4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidino]butanoic acid represented by the formula (I): wherein * represents an asymmetric carbon, which are excellent in antihistaminic activity and anti-allergic activity, and a process for producing the same.
  
  Patent expiration dates:
  
  
  • December 25, 2017
    
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • September 8, 2014 - NEW CHEMICAL ENTITY
  
  

See also...

• Bepreve Consumer Information (Drugs.com)
• Bepreve Eye Drops Consumer Information (Wolters Kluwer)
• Bepreve Consumer Information (Cerner Multum)
• Bepreve Advanced Consumer Information (Micromedex)
• Bepreve AHFS DI Monographs (ASHP)
• Bepotastine Eye Drops Consumer Information (Wolters Kluwer)
• Bepotastine ophthalmic Consumer Information (Cerner Multum)
• Bepotastine besilate Ophthalmic Advanced Consumer Information (Micromedex)
• Bepotastine Besilate AHFS DI Monographs (ASHP)

Sensodyne

Sensodyne may be available in the countries listed below.

Ingredient matches for Sensodyne

Strontium-89 Chloride

Strontium Chloride Sr 89 is reported as an ingredient of Sensodyne in the following countries:

• Canada


• Turkey

International Drug Name Search

Valsartan

In the US, Valsartan (valsartan systemic) is a member of the drug class angiotensin II inhibitors and is used to treat Heart Failure, High Blood Pressure and Left Ventricular Dysfunction.

US matches:

• Valsartan


• Valsartan/Hydrochlorothiazide


• Valsartan and hydrochlorothiazide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C09CA03

CAS registry number (Chemical Abstracts Service)

0137862-53-4

Chemical Formula

C24-H29-N5-O3

Molecular Weight

435

Therapeutic Categories

Antihypertensive agent

Angiotensin-II antagonist

Chemical Name

N-[p-(o-1H-Tetrazol-5-ylphenyl)benzyl]-N-valeryl-L-valine

Foreign Names

• Valsartanum (Latin)
• Valsartan (German)
• Valsartan (French)
• Valsartan (Spanish)

Generic Names

• Valsartan (OS: USAN, BAN, DCF)
• CGP 48933 (IS: Ciba-Geigy)
• Valsartan (PH: USP 32)

Brand Names

• Alpertan
  Raffo, Argentina



• Alsart
  Meyer, Venezuela



• Alsartan
  Fluter, Dominican Republic



• Arovan
  Aristopharma, Bangladesh



• Cardival
  Drug International, Bangladesh



• Co Diovan Forte (Valsartan and Hydrochlorothiazide)
  Novartis, Spain



• Co Diovan (Valsartan and Hydrochlorothiazide)
  Novartis, Spain



• Co Vals Forte (Valsartan and Hydrochlorothiazide)
  Laboratorios Dr Esteve, Spain



• Co Vals (Valsartan and Hydrochlorothiazide)
  Laboratorios Dr Esteve, Spain



• CoDiovan (Valsartan and Hydrochlorothiazid)
  Novartis, Bangladesh; Novartis, Germany; Novartis, Slovakia; Novartis, Thailand



• Co-Diovan (Valsartan and Hydrochlorothiazide)
  Dr. Fisher, Netherlands; Eureco, Netherlands; Euro, Netherlands; Medcor, Netherlands; Novartis, Austria; Novartis, Australia; Novartis, Bulgaria; Novartis, Bahrain; Novartis, Switzerland; Novartis, China; Novartis, Denmark; Novartis, United Kingdom; Novartis, Croatia (Hrvatska); Novartis, Indonesia; Novartis, Ireland; Novartis, Malta; Novartis, Netherlands; Novartis, Oman; Novartis, Poland; Novartis, Singapore; Novartis, Slovenia; Novartis, Vietnam; Novartis, South Africa



• Co-Diovane (Valsartan and Hydrochlorothiazide)
  Novartis, Belgium



• Combisartan (Valsartan and Hydrochlorothiazide)
  Menarini, Italy



• Cordinate
  AWD.pharma, Germany



• Cordinate plus (Valsartan and Hydrochlorothiazide)
  AWD.pharma, Germany



• Corixil Orifarm (Valsartan and Hydrochlorothiazide)
  Novartis, Denmark



• Corixil (Valsartan and Hydrochlorothiazide)
  LPB, Italy



• Cotareg orifarm (Valsartan and Hydrochlorothiazide)
  Novartis, Denmark



• Cotareg Paranova (Valsartan and Hydrochlorothiazide)
  Novartis, Denmark



• Cotareg PharmaCoDane (Valsartan and Hydrochlorothiazide)
  Novartis, Denmark



• Cotareg (Valsartan and Hydrochlorothiazide)
  Novartis, France; Novartis, Italy; Novartis, Tunisia



• Co-Tareg (Valsartan and Hydrochlorothiazide)
  Novartis, South Africa



• Co-Valsartan-Mepha (Valsartan and Hydrochlorothiazide)
  Mepha Pharma, Switzerland



• Dafiro (Valsartan and Amlodipin)
  Novartis, Greece; Schwarz, Germany



• Dalzad
  Novartis, Greece



• Diovan Cardio
  Novartis, Spain



• Diovan Comp. (Valsartan and Hydrochlorothiazide)
  Novartis, Denmark



• Diovan HCT (Valsartan and Hydrochlorothiazide)
  Novartis, Canada; Novartis, Hungary; Novartis, United States; Novartis Pharmaceuticals, Peru



• Diovan
  Allpack, Bulgaria; Eureco, Netherlands; Euro, Netherlands; Konapharm, Bulgaria; Medcor, Netherlands; Novartis, Argentina; Novartis, Austria; Novartis, Australia; Novartis, Bosnia & Herzegowina; Novartis, Bangladesh; Novartis, Bulgaria; Novartis, Bahrain; Novartis, Brazil; Novartis, Canada; Novartis, Switzerland; Novartis, China; Novartis, Colombia; Novartis, Germany; Novartis, Denmark; Novartis, Ecuador; Novartis, Estonia; Novartis, Spain; Novartis, Finland; Novartis, United Kingdom; Novartis, Georgia; Novartis, Greece; Novartis, Guyana; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, India; Novartis, Iceland; Novartis, Japan; Novartis, Sri Lanka; Novartis, Lithuania; Novartis, Luxembourg; Novartis, Latvia; Novartis, Malta; Novartis, Mexico; Novartis, Malaysia; Novartis, Netherlands; Novartis, Norway; Novartis, Oman; Novartis, Philippines; Novartis, Poland; Novartis, Portugal; Novartis, Romania; Novartis, Serbia; Novartis, Russian Federation; Novartis, Sweden; Novartis, Singapore; Novartis, Slovenia; Novartis, Slovakia; Novartis, Thailand; Novartis, Turkey; Novartis, Taiwan; Novartis, United States; Novartis, Venezuela; Novartis, Vietnam; Novartis, South Africa; Novartis Pharmaceuticals, Peru



• Diovan Comp (Valsartan and Hydrochlorothiazide)
  Novartis, Finland; Novartis, Sweden



• Diovane Paranova
  Novartis, Denmark



• Diovane
  Novartis, Belgium



• Disys Plus (Valsartan and Hydrochlorothiazid)
  Healthcare, Bangladesh



• Disys
  Healthcare, Bangladesh



• Dosara
  Andromaco, Chile



• Exforge (Valsartan and Amlodipine)
  Novartis, Australia; Novartis, Belgium; Novartis, Bahrain; Novartis, Switzerland; Novartis, China; Novartis, Germany; Novartis, Finland; Novartis, France; Novartis, United Kingdom; Novartis, Greece; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Indonesia; Novartis, Ireland; Novartis, Netherlands; Novartis, Norway; Novartis, Sweden; Novartis, Singapore; Novartis, Slovenia; Novartis, Slovakia; Novartis, United States; Novartis, South Africa; Novartis Europharm, Austria; Novartis Europharm Ltd., Denmark; Novartis Pharmaceuticals, Peru



• Kalpress Cardio
  Lacer, Spain



• Kalpress Plus (Valsartan and Hydrochlorothiazide)
  Lacer, Spain



• Kalpress
  Lacer, Spain



• Miten Cardio
  Schwarz, Spain



• Miten Plus Forte (Valsartan and Hydrochlorothiazide)
  Schwarz, Spain



• Miten Plus (Valsartan and Hydrochlorothiazide)
  Schwarz, Spain



• Miten
  Schwarz, Spain



• Nisis
  Ipsen, France



• Nisisco (Valsartan and Hydrochlorothiazide)
  Ipsen, France



• Provas
  Sanol, Germany; Schwarz, Germany



• Provas comp (Valsartan and Hydrochlorothiazide)
  Sanol, Germany; Schwarz, Germany



• Ramartan
  Nucleus, Poland



• Rixil
  Bracco, Italy



• Sarteg HCT (Valsartan andHydrochlorothiazide)
  Actavis, Bulgaria



• Sarteg
  Actavis, Bulgaria



• Sarval
  Baliarda, Argentina



• Simultan
  Lazar, Argentina; Lazar, Ecuador



• Starval
  Ranbaxy, India; Ranbaxy, Peru



• Tareg
  Jaba, Portugal; Novartis, Burkina Faso; Novartis, Congo; Novartis, Cote D'ivoire; Novartis, Chile; Novartis, Algeria; Novartis, France; Novartis, Gabon; Novartis, Guinea; Novartis, Italy; Novartis, Madagascar; Novartis, Mauritius; Novartis, Senegal; Novartis, Togo; Novartis, Tunisia; Novartis, South Africa; Novartis, Zaire



• Teval (Valsartan and Hydrochlorothiazide)
  Teva, Slovakia



• Val
  Belupo, Croatia (Hrvatska)



• Val plus (Valsartan and Hydrochlorothiazide)
  Belupo, Croatia (Hrvatska)



• Valaplex
  Chile, Chile



• Valcap
  Beximco, Bangladesh



• Valitazin
  Medis, Poland



• Valpresan
  SM Pharma, Venezuela



• Valpress
  Silva, Bangladesh



• Valpression
  Menarini, Italy



• Vals Cardio
  Laboratorios Dr Esteve, Spain



• Vals
  Laboratorios Dr Esteve, Spain



• Valsabela
  Belupo, Slovakia



• Valsacor
  Krka, Estonia; Krka, Croatia (Hrvatska); Krka, Lithuania; Krka, Latvia; Krka, Poland; Krka, Slovenia; Krka, Slovakia



• Valsan
  Mystic, Bangladesh



• Valsaprex
  Heimdall, Colombia



• Valsar
  Euro, Dominican Republic



• Valsartán Calox
  Calox, Venezuela



• Valsartan Genfar
  Genfar, Colombia; Genfar, Ecuador



• Valsartan HCT Streuli (Valsartan and Hydrochlorothiazide)
  Streuli Pharma, Switzerland



• Valsartan Mepha
  Mepha Pharma, Switzerland



• Valsartan MK
  McKesson, Ecuador; MK, Colombia



• Valsartan Northia
  Northia, Argentina



• Valsartan Nucleus
  Nucleus, Slovakia



• Valsartan Pliva
  Pliva, Slovakia



• Valsartan/HCT-Teva (Valsartan and Hydrochlorothiazide)
  Teva Pharma, Switzerland



• Valsartan+pharma
  +pharma, Slovakia



• Valsartán
  Genéricos RxI.M.G. Rx, Venezuela; Genéricos Venezolanos, Venezuela; Meyer, Venezuela



• Valsartan-NI
  Dexa Medica, Indonesia



• Valt
  Cheminter, Guatemala



• Valtan
  Lafrancol, Colombia; Lafrancol, Guatemala



• Valturna (Valsartan and Aliskiren)
  Novartis, United States



• Valzaar
  Torrent, Myanmar



• Valzek
  Celon, Poland



• Valzide (Valsartan and Hydrochlorothiazide)
  Renata, Bangladesh



• Varexan
  Novartis, Hungary



• Vartalan
  Drugtech-Recalcine, Chile; Recalcine, Ecuador



• Vasaten
  Leti, Venezuela



• Yosovaltan
  Ozone Laboratories, Poland

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Somin

Somin may be available in the countries listed below.

Ingredient matches for Somin

Dexchlorpheniramine

Dexchlorpheniramine maleate (a derivative of Dexchlorpheniramine) is reported as an ingredient of Somin in the following countries:

• Singapore

International Drug Name Search

Soludamin

Soludamin may be available in the countries listed below.

Ingredient matches for Soludamin

Levocarnitine

Levocarnitine is reported as an ingredient of Soludamin in the following countries:

• Greece

International Drug Name Search

Zimecterin EZ

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Zimecterin EZ

Ivermectin

Ivermectin is reported as an ingredient of Zimecterin EZ in the following countries:

• United States

International Drug Name Search

Olcadil

Olcadil may be available in the countries listed below.

Ingredient matches for Olcadil

Cloxazolam

Cloxazolam is reported as an ingredient of Olcadil in the following countries:

• Brazil


• Portugal

International Drug Name Search

Dulcolax Pico

Dulcolax Pico may be available in the countries listed below.

Ingredient matches for Dulcolax Pico

Sodium Picosulfate

Sodium Picosulfate monohydrate (a derivative of Sodium Picosulfate) is reported as an ingredient of Dulcolax Pico in the following countries:

• Bulgaria

International Drug Name Search

Peptic Ulcer with Obstruction Medications

There are currently no drugs listed for "Peptic Ulcer with Obstruction".

Learn more about Peptic Ulcer with Obstruction

Micromedex Care Notes:

• Peptic Ulcer

Medical Encyclopedia:

• Erosion
• Gastric ulcer
• Peptic ulcer

Drug List:

Noostan

Noostan may be available in the countries listed below.

Ingredient matches for Noostan

Piracetam

Piracetam is reported as an ingredient of Noostan in the following countries:

• Argentina


• Portugal

International Drug Name Search

Nalorfina

Nalorfina may be available in the countries listed below.

Ingredient matches for Nalorfina

Nalorphine

Nalorfina (DCIT) is also known as Nalorphine (Rec.INN)

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Fosamax

Fosamax is a brand name of alendronate, approved by the FDA in the following formulation(s):

FOSAMAX (alendronate sodium - solution; oral)

• 
  Manufacturer: MERCK
  
  Approval date: September 17, 2003
  
  Strength(s): EQ 70MG BASE/75ML ^[RLD]

FOSAMAX (alendronate sodium - tablet; oral)

• 
  Manufacturer: MERCK AND CO INC
  
  Approval date: September 29, 1995
  
  Strength(s): EQ 10MG BASE ^[AB], EQ 40MG BASE ^[AB]


• 
  Manufacturer: MERCK AND CO INC
  
  Approval date: April 25, 1997
  
  Strength(s): EQ 5MG BASE ^[AB]


• 
  Manufacturer: MERCK AND CO INC
  
  Approval date: October 20, 2000
  
  Strength(s): EQ 35MG BASE ^[AB], EQ 70MG BASE ^[RLD][AB]

Has a generic version of Fosamax been approved?

A generic version of Fosamax has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Fosamax and have been approved by the FDA:

alendronate sodium tablet; oral

• 
  Manufacturer: APOTEX
  
  Approval date: August 4, 2008
  
  Strength(s): EQ 10MG BASE ^[AB], EQ 35MG BASE ^[AB], EQ 5MG BASE ^[AB], EQ 70MG BASE ^[AB]


• 
  Manufacturer: AUROBINDO PHARMA
  
  Approval date: August 4, 2008
  
  Strength(s): EQ 10MG BASE ^[AB], EQ 35MG BASE ^[AB], EQ 70MG BASE ^[AB]


• 
  Manufacturer: AUSTARPHARMA LLC
  
  Approval date: September 24, 2009
  
  Strength(s): EQ 10MG BASE ^[AB], EQ 35MG BASE ^[AB], EQ 5MG BASE ^[AB], EQ 70MG BASE ^[AB]


• 
  Manufacturer: CADISTA PHARMS
  
  Approval date: February 18, 2010
  
  Strength(s): EQ 10MG BASE ^[AB], EQ 35MG BASE ^[AB], EQ 5MG BASE ^[AB], EQ 70MG BASE ^[AB]


• 
  Manufacturer: DR REDDYS LABS LTD
  
  Approval date: August 4, 2008
  
  Strength(s): EQ 10MG BASE ^[AB], EQ 35MG BASE ^[AB], EQ 5MG BASE ^[AB], EQ 70MG BASE ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: August 4, 2008
  
  Strength(s): EQ 10MG BASE ^[AB], EQ 35MG BASE ^[AB], EQ 35MG BASE ^[AB], EQ 5MG BASE ^[AB], EQ 70MG BASE ^[AB], EQ 70MG BASE ^[AB]


• 
  Manufacturer: SUN PHARMA GLOBAL
  
  Approval date: September 10, 2008
  
  Strength(s): EQ 10MG BASE ^[AB], EQ 35MG BASE ^[AB], EQ 5MG BASE ^[AB], EQ 70MG BASE ^[AB]


• 
  Manufacturer: TEVA PHARMS
  
  Approval date: February 6, 2008
  
  Strength(s): EQ 10MG BASE ^[AB], EQ 35MG BASE ^[AB], EQ 40MG BASE ^[AB], EQ 5MG BASE ^[AB], EQ 70MG BASE ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: August 4, 2008
  
  Strength(s): EQ 10MG BASE ^[AB], EQ 35MG BASE ^[AB], EQ 35MG BASE ^[AB], EQ 40MG BASE ^[AB], EQ 40MG BASE ^[AB], EQ 5MG BASE ^[AB], EQ 70MG BASE ^[AB], EQ 70MG BASE ^[AB]

Note: No generic formulation of the following product is available.

• alendronate sodium - solution; oral

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Fosamax. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Dry mix formulation for bisphosphonic acids with lactose
  Patent 5,358,941
  Issued: October 25, 1994
  Inventor(s): Bechard; Simon R. & Kramer; Kenneth A. & Katdare; Ashok V.
  Assignee(s): Merck & Co., Inc.
  Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by direct compression/dry mix tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease.
  
  Patent expiration dates:
  
  
  • December 2, 2012
    
  
  
  
  • June 2, 2013
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Oral liquid alendronate formulations
  Patent 5,462,932
  Issued: October 31, 1995
  Inventor(s): Brenner; Gerald S. & Katdare; Ashok V. & Pretzer; Denise & Whiteford; Donna T.
  Assignee(s): Merck & Co., Inc.
  Disclosed is a therapy protocol for treating and for preventing bone loss in patients who have difficulty in swallowing by administering a liquid formulation of alendronate which can be easily swallowed. Also described are pharmaceutical dosage forms of a syrup, aqueous solution, a solution formed from a reconstituted powder, of alendronate, for carrying out the therapeutic method.
  
  Patent expiration dates:
  
  
  • May 17, 2014
    
  
  
  
  • November 17, 2014
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Dry mix formulation for bisphosphonic acids
  Patent 5,681,590
  Issued: October 28, 1997
  Inventor(s): Bechard; Simon R. & Kramer; Kenneth A. & Katdare; Ashok V.
  Assignee(s): Merck & Co., Inc.
  Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by direct compression/dry mix tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease.
  
  Patent expiration dates:
  
  
  • December 2, 2012
    
  
  
  
  • June 2, 2013
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Method for inhibiting bone resorption
  Patent 5,994,329
  Issued: November 30, 1999
  Inventor(s): Daifotis; Anastasia G. & Santora, II; Arthur C. & Yates; A. John
  Assignee(s): Merck & Co., Inc.
  Disclosed are methods for inhibiting bone resorption in mammals while minimizing the occurrence of or potential for adverse gastrointestinal effects. Also disclosed are pharmaceutical compositions and kits for carrying out the therapeutic methods disclosed herein.
  
  Patent expiration dates:
  
  
  • July 17, 2018
    
    ✓ 
    Sponsor has requested patent be delisted
  
  
  
  • January 17, 2019
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Method for inhibiting bone resorption
  Patent 6,015,801
  Issued: January 18, 2000
  Inventor(s): Daifotis; Anastasia G. & Yates; A. John & Santora, II; Arthur C.
  Assignee(s): Merck & Co., Inc.
  Disclosed are methods for inhibiting bone resorption in mammals while minimizing the occurrence of or potential for adverse gastrointestinal effects. Also disclosed are pharmaceutical compositions and kits for caring out the therapeutic methods disclosed herein.
  
  Patent expiration dates:
  
  
  • July 17, 2018
    
    ✓ 
    Sponsor has requested patent be delisted
  
  
  
  • January 17, 2019
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Dry mix formulation for bisphosphonic acids
  Patent 6,090,410
  Issued: July 18, 2000
  Inventor(s): Bechard; Simon R. & Kramer; Kenneth A. & Katdare; Ashok V.
  Assignee(s): Merck & Co., Inc.
  Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by direct compression/dry mix tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease.
  
  Patent expiration dates:
  
  
  • December 2, 2012
    
  
  
  
  • June 2, 2013
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Dry mix formulation for bisphosphonic acids
  Patent 6,194,004
  Issued: February 27, 2001
  Inventor(s): Bechard; Simon R. & Kramer; Kenneth A. & Katdare; Ashok V.
  Assignee(s): Merck & Co., Inc.
  Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by direct compression/dry mix tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease.
  
  Patent expiration dates:
  
  
  • December 2, 2012
    
  
  
  
  • June 2, 2013
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Method for inhibiting bone resorption
  Patent 6,225,294
  Issued: May 1, 2001
  Inventor(s): Daifotis; Anastasia G. & Santora, II; Arthur C. & Yates; A. John
  Assignee(s): Merck & Co., Inc.
  Disclosed are methods for inhibiting bone resorption in mammals while minimizing the occurrence of or potential for adverse gastrointestinal effects. Also disclosed are pharmaceutical compositions and kits for carrying out the therapeutic methods disclosed herein.
  
  Patent expiration dates:
  
  
  • July 17, 2018
    
    ✓ 
    Sponsor has requested patent be delisted
  
  
  
  • January 17, 2019
    
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Fosamax Consumer Information (Drugs.com)
• Fosamax Consumer Information (Wolters Kluwer)
• Fosamax Solution Consumer Information (Wolters Kluwer)
• Fosamax Consumer Information (Cerner Multum)
• Fosamax Advanced Consumer Information (Micromedex)
• Fosamax AHFS DI Monographs (ASHP)
• Alendronate Consumer Information (Wolters Kluwer)
• Alendronate Solution Consumer Information (Wolters Kluwer)
• Alendronate Consumer Information (Cerner Multum)
• Alendronate Advanced Consumer Information (Micromedex)
• Alendronate Sodium AHFS DI Monographs (ASHP)